Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents

References

• Cryer B. NSAID-associated deaths: the rise and fall of NSAID-associated GI mortality. Am J Gastroenterol. 2005;100:1694–1695.
   PubMed Web of Science ®Google Scholar
• Smith WL, Song I. The enzymology of prostaglandin endoperoxide H synthases-1 and-2. Prostagland Other Lipid Mediat. 2002;68-69:115–128.
   PubMed Web of Science ®Google Scholar
• FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001;345:433–442.
   PubMed Web of Science ®Google Scholar
• Fu J-Y, Masferrer J, Seibert K, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 1990;265(28):16737–16740.
   PubMed Web of Science ®Google Scholar
• Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. 1996;384(6610):644–648.
   PubMed Web of Science ®Google Scholar
• Dannhardt G, Kiefer W. Cyclooxygenase inhibitors–current status and future prospects. Eur J Med Chem. 2001;36:109–126.
   PubMed Web of Science ®Google Scholar
• Lipsky P. Progress toward a new class of therapeutics: selective COX-2 inhibition: introduction and course description. J Rheumatol Suppl. 1997;24:1–5.
   Google Scholar
• Lane NE. Pain management in osteoarthritis: the role of COX-2 inhibitors. J Rheumatol Suppl. 1997;49:20–24.
   PubMedGoogle Scholar
• Marnett LJ, Kalgutkar AS. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Trends Pharmacol Sci. 1999;20(11):465–469.
   PubMed Web of Science ®Google Scholar
• Gierse JK, McDonald JJ, Hauser SD, Rangwala SH, Koboldt CM, Seibert K. A single amino acid difference between cyclooxygenase-1 (COX-1) and− 2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. J Biol Chem. 1996;271(26):15810–15814.
   PubMed Web of Science ®Google Scholar
• Bromm B, Forth W, Richter E, Scharein E. Effects of acetaminophen and antipyrine on non-inflammatory pain and EEG activity. Pain. 1992;50:213–221.
   PubMed Web of Science ®Google Scholar
• El Sayed MT, El-Sharief MAS, Zarie ES, Morsy NM, Elsheakh AR, Voronkov A, Berishvili V, Hassan GS. Design, synthesis, anti-inflammatory activity and molecular docking of potential novel antipyrine and pyrazolone analogs as cyclooxygenase enzyme (COX) inhibitors. Bioorg Med Chem Lett. 2018;28:952–957.
   PubMed Web of Science ®Google Scholar
• Turan-Zitouni G, Sıvacı M, Kılıç FS, Erol K. Synthesis of some triazolyl-antipyrine derivatives and investigation of analgesic activity. Eur J Med Chem. 2001;36:685–689.
   PubMed Web of Science ®Google Scholar
• Domiati SA, Abd El Galil KH, Abourehab MA, Ibrahim TM, Ragab HM. Structure-guided approach on the role of substitution on amide-linked bipyrazoles and its effect on their anti-inflammatory activity. J Enzyme Inhib Med Chem. 2022;37:2179–2190.
   PubMed Web of Science ®Google Scholar
• Karati D, Mahadik KR, Kumar D. Pyrazole Scaffolds: Centrality in Anti-Inflammatory and Antiviral Drug Design. Med Chem. 2022;18(10):1060–1072.
   PubMed Web of Science ®Google Scholar
• Yao H, Guo Q, Wang M, Wang R, Xu Z. Discovery of pyrazole N-aryl sulfonate: A novel and highly potent cyclooxygenase-2 (COX-2) selective inhibitors. Bioorg Med Chem. 2021;46:116344.
   PubMed Web of Science ®Google Scholar
• Palaska E, Sahin G, Kelicen P, Durlu NT, Altinok G. Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1, 3, 4-oxadiazoles, 1, 3, 4-thiadiazoles and 1, 2, 4-triazole-3-thiones. Farmaco. 2002;57:101–107.
   PubMedGoogle Scholar
• Nargund L, Reddy G, Hariprasad V. Anti-inflammatory activity of substituted 1, 3, 4-oxadiazoles. J Pharm Sci. 1994;83:246–248.
   PubMed Web of Science ®Google Scholar
• Ravindra K, Vagdevi H, Vaidya V, Padmashali B. Synthesis, antimicrobial and antiinflammatory activities of 1, 3, 4-oxadiazoles linked to naphtho [2, 1-b] furan, 2006.
   Google Scholar
• Glomb T, Wiatrak B, Gębczak K, Gębarowski T, Bodetko D, Czyżnikowska Ż, Świątek P. New 1, 3, 4-Oxadiazole Derivatives of Pyridothiazine-1, 1-Dioxide with Anti-Inflammatory Activity. IJMS. 2020;21(23):9122.
   Google Scholar
• Karegoudar P, Prasad DJ, Ashok M, Mahalinga M, Poojary B, Holla BS. Synthesis, antimicrobial and anti-inflammatory activities of some 1, 2, 4-triazolo [3, 4-b][1, 3, 4] thiadiazoles and 1, 2, 4-triazolo [3, 4-b][1, 3, 4] thiadiazines bearing trichlorophenyl moiety. Eur J Med Chem. 2008;43:808–815.
   PubMed Web of Science ®Google Scholar
• Jadhav V, Kulkarni M, Rasal V, Biradar S, Vinay M. Synthesis and anti-inflammatory evaluation of methylene bridged benzofuranyl imidazo. Eur J Med Chem. 2008;43:1721–1729.
   PubMed Web of Science ®Google Scholar
• Rostom SA, El-Ashmawy IM, Abd El Razik HA, Badr MH, Ashour HM. Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents. Bioorg Med Chem. 2009;17:882–895.
   PubMed Web of Science ®Google Scholar
• Amir M, Javed S, Kumar H. Pyrimidine as antiinflammatory agent: A review. Indian J Pharm Sci. 2007;69:337.
   Google Scholar
• Ur Rashid H, Martines MAU, Duarte AP, Jorge J, Rasool S, Muhammad R, Ahmad N, Umar MN. Research developments in the syntheses, anti-inflammatory activities and structure–activity relationships of pyrimidines. RSC Adv. 2021;11(11):6060–6098.
   PubMed Web of Science ®Google Scholar
• Sondhi SM, Jain S, Dwivedi AD, Shukla R, Raghubir R. Synthesis of condensed pyrimidines and their evaluation for anti-inflammatory and analgesic activities, 2008.
   Google Scholar
• Sahu M, Siddiqui N. A review on biological importance of pyrimidines in the new era. Int J Pharm Pharm Sci. 2016;8:8–21.
   Web of Science ®Google Scholar
• Chawla G, Naaz B, Siddiqui AA. Exploring 1, 3, 4-oxadiazole scaffold for anti-inflammatory and analgesic activities: a review of literature from. Mini Rev Med Chem. 2018;18:216–233.
   PubMed Web of Science ®Google Scholar
• Yerragunta V, Patil P, Anusha V, Kumaraswamy T, Suman D, Samhitha T. Pyrimidine and its biological activity: a review, PharmaTutor. 2013;1(2):39–44.
   Google Scholar
• Sondhi SM, Singh N, Johar M, Kumar A. Synthesis, anti-inflammatory and analgesic activities evaluation of some mono, bi and tricyclic pyrimidine derivatives. Bioorg Med Chem. 2005;13(22):6158–6166.
   PubMed Web of Science ®Google Scholar
• Willis PA, Bonnert RV, Hunt SF, Walters IAS. Novel thiazolo (4, 5-d) pyrimidine compounds novel compounds, in, Google Patents, 2009.
   Google Scholar
• Patil V, Tilekar K, Mehendale-Munj S, Mohan R, Ramaa C. Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2, 4-thiazolidinedione derivatives. Eur J Med Chem. 2010;45(10):4539–4544.
   PubMed Web of Science ®Google Scholar
• Yu W, Cheng LP, Pang W, Guo LL. Design, Synthesis and Biological Evaluation of Novel 1, 3, 4-Oxadiazole Derivatives as Potent Neuraminidase Inhibitors. Bioorg Med Chem. 2022; 57:116647.
   PubMed Web of Science ®Google Scholar
• Upadhyay PK, Mishra P. Microwave assisted synthesis and evaluation of some substituted 1, 3, 4-oxadiazoles as free radical scavenger. J Indian Chem Soc. 2018;95:661–666.
   Web of Science ®Google Scholar
• Karabanovich G, Zemanová J, Smutný T, Székely R, Šarkan M, Centárová I, Vocat A, Pávková I, Čonka P, Němeček J, et al. Development of 3, 5-dinitrobenzylsulfanyl-1, 3, 4-oxadiazoles and thiadiazoles as selective antitubercular agents active against replicating and nonreplicating Mycobacterium tuberculosis. J Med Chem. 2016;59:2362–2380.
   PubMed Web of Science ®Google Scholar
• Ma C-L, Tian G-R, Zhang R-F. Investigation on steric effect in the coordination of S, N and O donor heterocycle to organotin (IV): Syntheses and crystal structures of triorganotin (IV) derivatives with 5-phenyl-1, 3, 4-oxadiazole-2-thiol. Polyhedron. 2005;24(13):1773–1780.
   Web of Science ®Google Scholar
• Li W, Chu J, Fan T, Zhang W, Yao M, Ning Z, Wang M, Sun J, Zhao X, Wen A. Design and synthesis of novel 1-phenyl-3-(5-(pyrimidin-4-ylthio)-1, 3, 4-thiadiazol-2-yl) urea derivatives with potent anti-CML activity throughout PI3K/AKT signaling pathway. Bioorg Med Chem Lett. 2019;29(14):1831–1835.
   PubMed Web of Science ®Google Scholar
• Jacobsen EJ, Mitchell MA, Hendges SK, Belonga KL, Skaletzky LL, Stelzer LS, Lindberg TJ, Fritzen EL, Schostarez HJ, O'Sullivan TJ, et al. Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors. J Med Chem. 1999;42:1525–1536.
   PubMed Web of Science ®Google Scholar
• Al-Abdullah ES, Al-Obaid A-RM, Al-Deeb OA, Habib EE, El-Emam AA. Synthesis of novel 6-phenyl-2, 4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents. Eur J Med Chem. 2011;46:4642–4647.
   PubMed Web of Science ®Google Scholar
• Mohan SB, Kumar BR, Dinda S, Naik D, Seenivasan SP, Kumar V, Rana DN, Brahmkshatriya PS. Microwave-assisted synthesis, molecular docking and antitubercular activity of 1, 2, 3, 4-tetrahydropyrimidine-5-carbonitrile derivatives. Bioorg Med Chem Lett. 2012;22(24):7539–7542.
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang L, Joo D, Sun S. Signal Transduct. Target. Ther. 2017;2:e17023.
   PubMed Web of Science ®Google Scholar
• Rouzer CA, Marnett LJ. Cyclooxygenases: structural and functional insights. J Lipid Res. 2009;50:S29–S34.
   PubMed Web of Science ®Google Scholar
• Mahesh G, Kumar KA, Reddanna P. Overview on the discovery and development of anti-inflammatory drugs: should the focus be on synthesis or degradation of PGE2? J Inflamm Res. 2021;14:253–263.
   PubMed Web of Science ®Google Scholar
• Del Valle DM, Kim-Schulze S, Huang H-H, Beckmann ND, Nirenberg S, Wang B, Lavin Y, Swartz TH, Madduri D, Stock A, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26(10):1636–1643.
   PubMed Web of Science ®Google Scholar
• Lawrence T. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1:a001651.
   PubMed Web of Science ®Google Scholar
• Houshmand G, Naghizadeh B, Ghorbanzadeh B, Ghafouri Z, Goudarzi M, Mansouri MT. Celecoxib inhibits acute edema and inflammatory biomarkers through peroxisome proliferator-activated receptor-γ in rats. Iran J Basic Med Sci. 2020;23(12):1544–1550.
   PubMed Web of Science ®Google Scholar
• Salvemini D, Kim SF, Mollace V. Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications. Am J Physiol Regul Integr Comp Physiol. 2013;304:R473–R487.
   PubMed Web of Science ®Google Scholar
• Bang JS, Oh DH, Choi HM, Sur B-J, Lim S-J, Kim JY, Yang H-I, Yoo MC, Hahm D-H, Kim KS. Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res Ther. 2009;11:R49–9.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang LY, Wright D, Parmely MJ. Redox imbalance differentially inhibits lipopolysaccharide-induced macrophage activation in the mouse liver. Infect Immun. 1999;67(10):5409–5416.
   PubMed Web of Science ®Google Scholar
• Di Capua A, Sticozzi C, Brogi S, Brindisi M, Cappelli A, Sautebin L, Rossi A, Pace S, Ghelardini C, Di Cesare Mannelli L, et al. Synthesis and biological evaluation of fluorinated 1, 5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity. Eur J Med Chem. 2016;109:99–106.
   PubMed Web of Science ®Google Scholar
• Saletti M, Maramai S, Reale A, Paolino M, Brogi S, Di Capua A, Cappelli A, Giorgi G, D'Avino D, Rossi A, et al. Novel analgesic/anti-inflammatory agents: 1, 5-Diarylpyrrole nitrooxyethyl sulfides and related compounds as Cyclooxygenase-2 inhibitors containing a nitric oxide donor moiety endowed with vasorelaxant properties. Eur J Med Chem. 2022;241:114615.
   PubMed Web of Science ®Google Scholar